# Hongke Baishi

> Hongke Baishi is a VC fund backing Medical, Pharmaceutical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Mar 2025
- Lead investor: 0%
- Last updated: Aug 2026

Hongke Baishi is a VC fund focused on Medical and Pharmaceutical. Hongke Baishi Investment Management is an investment company that focus on investments in innovation & technology.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Seed | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Juvensis Therapeutics | Juvensis Therapeutics is a gene therapy drug development company based on original mechanisms. | $13.8M | Seed | Mar 10, 2025 |  |
| Leadopharma | Leadopharma engages in the research and development of drugs targeting pain, epilepsy, depression, and neurodegenerative diseases. Leadopharma has established a complete pharmaceutical chemistry and ion channel drug research and development platform and team, which can independently carry out drug synthesis, activity screening, and early safetypharmacology research for ion channel targets. |  | Series A | Aug 07, 2023 |  |
| Feitong Bio | Feitong Bio platform discovers and develops innovative drugs using monoclonal antibody screening, molecular activity detection. | $15.7M | Series A | Dec 01, 2021 |  |

3 of 3 investments shown.

## Co-investors
- Chengdu Biocity — VC Fund, 1 deal together
- Dart Xia Yan Venture Capital — VC Fund, 1 deal together
- [Guofang Innovation](https://shizune.co/investors/profile/guofang-innovation) — VC Fund, 1 deal together
- [Hongfeng Investment Management](https://shizune.co/investors/profile/hongfeng-investment-management) — VC Fund, 1 deal together
- Jiangbei Technology Investment Group — VC Fund, 1 deal together
- Jinpu Muhe — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hongke Baishi invest in?

Hongke Baishi invests primarily in Medical, Pharmaceutical and Health Care startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hongke Baishi last invest?

The most recent investment recorded for Hongke Baishi closed in Mar 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co